NOV-1502

N/A

Report date: 2025/01/26 16:38:28
NME

Base Information

Drug NameNOV-1502
Drug Alias NameNOV-1502
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCatenin beta 1 modulatorsWingless type MMTV integration site family protein modulatorsGTPase Ras modulators
TargetsCatenin beta 1GTPase RasWingless type MMTV integration site family protein
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesYonsei University
China Registration ClassN/A

Develop Information

Active CompaniesYonsei University
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A